DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,289,046 | -10.7% | 5,196 | -13.6% | 0.15% | -7.8% |
| Q2 2023 | $1,443,154 | +10.1% | 6,013 | +15.6% | 0.17% | +4.4% |
| Q1 2023 | $1,311,123 | -4.1% | 5,202 | +1.0% | 0.16% | -7.0% |
| Q4 2022 | $1,367,221 | +6.8% | 5,151 | +3.9% | 0.17% | -3.4% |
| Q3 2022 | $1,280,000 | +48.8% | 4,956 | +46.2% | 0.18% | -8.2% |
| Q2 2022 | $860,000 | -39.2% | 3,391 | -29.6% | 0.19% | +15.5% |
| Q1 2022 | $1,414,000 | +5.8% | 4,819 | +18.7% | 0.17% | +4.3% |
| Q4 2021 | $1,336,000 | +8.1% | 4,061 | 0.0% | 0.16% | -2.4% |
| Q3 2021 | $1,236,000 | +89.3% | 4,061 | +67.0% | 0.16% | +14.6% |
| Q2 2021 | $653,000 | +28.3% | 2,432 | +7.6% | 0.14% | +16.1% |
| Q1 2021 | $509,000 | -6.9% | 2,261 | -8.1% | 0.12% | -12.7% |
| Q4 2020 | $547,000 | +39.9% | 2,461 | +35.4% | 0.14% | +16.4% |
| Q3 2020 | $391,000 | +43.2% | 1,817 | +17.7% | 0.12% | +28.4% |
| Q2 2020 | $273,000 | +30.0% | 1,544 | +12.7% | 0.10% | +25.0% |
| Q4 2019 | $210,000 | – | 1,370 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |